Global Gene Synthesis Market: Microfluidics Integration Exhibiting Significant Opportunity for the Industry

Global Gene Synthesis Market

Gene synthesis is the process utilized for the development of synthetic genes in a laboratory location, this method helps in bringing the text-based researches conducted by scientists and technically proficient individuals in real life-form sequences with high levels of accuracy and operational ease. It is commonly also known as DNA printing and comes under synthetic biology study. This process improves the developmental areas of sequencing, even developing gene sequences that are hard to develop from natural origins. This method is expected to have a positive impact on the overall synthetic biology model even allowing for overall expansion of the genetic codes currently available.

Access Full Report at https://databridgemarketresearch.com/reports/global-gene-synthesis-market/

Gene synthesis market is growing due to increasing emphasis on clinical research & development, advancements in the market & rising amount of healthcare expenditure; the effects of these factors are mentioned below:

  • Increasing emphasis on clinical research & development: Currently, biologics and life science organizations are majorly focusing on increasing their efficiency in developing various gene sequences and DNA codes. This has resulted in the major organizations emphasizing how much of their resources are invested in the development of research methods and how efficiently are they transforming these researches into real-life models. This involves utilizing the different clinical research methods or even focusing on developing greater efficient models in comparison to the methods currently available in the industry
  • Advancements in the market & rising amount of healthcare expenditure: Importantly, gene synthesis as a research method is also undergoing significant improvements and innovations as major biological companies focus on utilizing modern tools and instruments for their studies. This has also been backed by their strategy to improve the overall expenditure incurred on these studies and adopting the latest biological identification & development processes available

Product expansions and strategic acquisitions undertaken by the players:

  • In June 2019, GenScript announced that they had expanded “GenBrick Gene Synthesis” platform by inclusion of DNA sequences of up to 200kb long with complete accuracy. The platform is based on the recently developed proprietary technology helping high efficiency of DNA assembly in a single-step. This platform is set to meet the significant need of taking the issues with delays during the build phase of synthetic biology projects
  • In December 2017, GenScript Biotech Corp. announced that they had entered into an agreement for the acquisition of CustomArray Inc. in combination with their subsidiary GenScript USA Holding Inc. This acquisition will improve the existing product portfolio of GenScript Biotech Corp. relating to synthetic biology which will help their consumers in experiencing greater innovations in drug development. The combination of technologies of these companies will also improve the areas of applications for their innovations as they look to improve their customer base

The market is segmented on the basis of products & services as consumables, software, services; application is categorized into diagnostics, therapeutics, research & development activities, others; method is segmented into solid phase synthesis, chip based DNA synthesis, PCR based enzyme synthesis; end users is categorized as academic & research institutes, diagnostic laboratories, biotech & pharmaceutical companies, others.

“According to Data Bridge Market Research, global gene synthesis market is expected to be reach USD 19,295.56 million by 2026, growing with a healthy CAGR during the forecast period of 2019 to 2026”

Some of the major players operating in market are Thermo Fisher Scientific, Inc., Genewiz, Eurofins Scientific, ATD Bio Ltd., OriGene Technologies, Inc., Bioneer Corporation, Atum, Integrated DNA Technologies, Inc., GenScript, Eurogentec, Twist Bioscience., BioCat GmbH, LGC Biosearch Technologies, Eton Bioscience, Inc., Quintara Biosciences, Bio Basic Inc., SBS Genetech Co., Ltd., Merck KGaA among others.

Gene synthesis is also witnessing a valuable opportunity for their expansion in the life-science industry as its integration with microfluidics devices has improved the assembly and development sequence of gene pools. Microfluidic devices utilizing gene synthesis process helps in faster method of fabrication of development while also reducing the errors in the entire development process.